Dermatology Games

Isotretinoin (Accutane) Dosage Calculator — Cumulative Dose mg/kg

Dermatology · Clinical reference tool

Isotretinoin Cumulative Dose Calculator

Enter body weight and target cumulative dose to get total course dose in mg, duration in months and daily intensity in mg/kg/day. Handles both a single fixed dose and step-up schedules such as 20 mg → 30 mg → 40 mg.

Last updated 2 September 2026 · references checked against AAD 2024 and EuroGuiDerm 2025
Body weight
Target cumulative dose mg per kg over the whole course
Dosing plan
Daily dose mg taken per day
Already on treatment? Track how much is left
Days completed at this daily dose
Dose phases planning a new course? leave them unticked. following a patient? tick what is already done
Progress to target 0%
Completed Planned Still needed

Total course dose enter weight
Course length months
Treatment days at this daily dose
Expected finish if started today
Daily intensity — mg/kg/day
00.30.51.01.25+
ℹ️Results appear as soon as a weight is entered.
⚠️Pregnancy category X. Isotretinoin is teratogenic. Patients who can become pregnant require two forms of contraception, negative pregnancy tests before, during and after treatment, and enrolment in the applicable pregnancy-prevention programme (iPLEDGE in the US).
📩Email this dosing plan to yourself

Send the weight, daily dose, cumulative target, course length and expected finish date to your inbox, so you can check progress at each follow-up visit.

Sends your plan to your inbox right away. Occasional dermatology updates after. Unsubscribe any time.

Phase-by-phase breakdown

Each phase contributes its own share of the cumulative total. The teal row is the extra time needed at the final dose to reach the target.

PhaseDosemg/kg/dayDurationDeliveredCumulative

How long is the course at each cumulative target?

Same patient, same daily dose — only the cumulative target changes. Your selected target is highlighted.

Filled in below for a worked example of a 70 kg patient at 40 mg/day. Enter a weight above and the table recalculates for that patient.

Cumulative targetTotal doseDaysMonths
100 mg/kg7,000 mg1755.7
120 mg/kg8,400 mg2106.9
150 mg/kg10,500 mg2638.6
220 mg/kg15,400 mg38512.6

Worked examples: isotretinoin cumulative dose by body weight

The arithmetic is simple: total course dose = body weight in kg × cumulative target in mg/kg, and course length in days = total dose ÷ daily dose. The tables below are pre-calculated at a daily dose of 40 mg, so the numbers can be read without entering anything.

Example. A 70 kg patient with a 120 mg/kg target needs 70 × 120 = 8,400 mg in total. At 40 mg/day that is 8,400 ÷ 40 = 210 days, about 6.9 months, at a daily intensity of 40 ÷ 70 = 0.57 mg/kg/day — inside the conventional 0.5–1.0 mg/kg/day band.

Total dose and course length at 120 mg/kg (40 mg/day)

Body weightTotal course doseDays at 40 mg/dayMonths
50 kg (110 lb)6,000 mg1504.9
60 kg (132 lb)7,200 mg1805.9
70 kg (154 lb)8,400 mg2106.9
80 kg (176 lb)9,600 mg2407.9
90 kg (198 lb)10,800 mg2708.9
100 kg (220 lb)12,000 mg3009.9

Total dose and course length at 150 mg/kg (40 mg/day)

Body weightTotal course doseDays at 40 mg/dayMonths
50 kg (110 lb)7,500 mg1886.2
60 kg (132 lb)9,000 mg2257.4
70 kg (154 lb)10,500 mg2638.6
80 kg (176 lb)12,000 mg3009.9
90 kg (198 lb)13,500 mg33811.1
100 kg (220 lb)15,000 mg37512.3

Worked example of a step-up (titration) schedule

A dose that changes part-way through is where cumulative-dose arithmetic usually goes wrong: each phase contributes only its own days × daily dose, and the final dose then continues until the target is met. For a 70 kg patient with a 120 mg/kg target (8,400 mg) started low to blunt an early flare:

PhaseDaily dosemg/kg/dayDurationDeliveredCumulative
120 mg0.2930 days600 mg600 mg
230 mg0.4330 days900 mg1,500 mg
340 mg0.57173 days (to target)6,900 mg8,400 mg

Total course length 233 days ≈ 7.7 months — about 23 days longer than the same patient held at 40 mg/day from day one. Use Step-up schedule mode in the calculator above to model any other combination, or to enter what a patient has already taken and see what is left.

Quick conversions

Weight: 1 lb = 0.4536 kg · Months: 1 month = 30.44 days · Daily intensity: daily dose ÷ weight in kg. Below 0.3 mg/kg/day is very low dose, 0.3–1.0 mg/kg/day is conventional, and above 1.0 mg/kg/day is high and warrants closer monitoring.

Isotretinoin: 13 questions answered with the current evidence

Isotretinoin is the single most effective treatment for severe and treatment-resistant acne — and the most misunderstood. Much of what circulates online dates from the 1980s, or from case reports that larger studies have since failed to confirm. Each answer below is anchored to a linked source.

🗂️ Quick reference summary

⏱️ TimelineLess oil by week 2–4; visible clearing week 4–8; course 4–5 months.
💊 Low dose10 mg/day cleared 100% of 150 patients at a mean of 24 weeks; 4% mild relapse.
🔄 PurgeEarly flare in up to ~32%, first month, mostly mild — treatable, not therapeutic.
🧠 MoodNo increased population-level psychiatric risk across 1.6 million patients — but still screen.
💇 Hair3.2% at low dose vs 5.7% at higher dose; telogen effluvium, regrows in 3–12 months.
📊 Relapse22.5% relapse, 8.2% need a second course; median 7.5 months.
🛑 When to stopClear of active lesions, then 1–2 more months; 120–150 mg/kg is a guide, not a finish line.
🛑 Stopping earlyNo withdrawal, but relapse rises if residual lesions remain at the end.
🤰 PregnancyAbsolute contraindication — stop immediately and contact the prescriber.
✨ LasersHair removal and fractional lasers supported by consensus; no dermabrasion or full ablation.
🧴 SkincareCleanser, moisturiser, SPF 30+. No acids, retinol, BPO or vitamin A supplements.
Question 01

How long does isotretinoin (Accutane) take to work?

⏱ Typical course: 4–5 months

Oiliness falls within the first 2–4 weeks; visible improvement in lesions usually begins at 4–8 weeks. A standard course runs about 4 to 5 months, and the skin often continues to clear for a period after the medication is stopped.

Roughly 85% of patients respond within a 4-month course, while about 15% need longer — occasionally up to 10 months. Slow responders often have macrocomedones or an underlying hormonal driver.

📚 Reference: American Academy of Dermatology — Isotretinoin FAQs ↗

Question 02

Is a 10 mg daily dose of isotretinoin effective for acne?

✅ Effective for moderate acne — slower

Yes for most moderate acne, but it takes longer. In a prospective study of 150 patients given a fixed 10 mg daily dose until a cumulative dose of 90–110 mg/kg, all achieved total clearance at a mean of 24 weeks, with mild relapse in only 4%. Patients with severe or very severe acne took considerably longer to clear (32.9 vs 19.1 weeks).

RegimenTypical time to clearancePositioning
10 mg/day (low dose)~24 weeksModerate acne
0.5–1.0 mg/kg/day (conventional)~16–20 weeksSevere / nodulocystic
Key point: Long-term remission tracks more closely with how long the oil glands stay suppressed than with the daily milligram count. Use the calculator above in Step-up schedule mode to see how much longer a 10 mg course runs to reach the same cumulative target.

📚 Reference: Yap FB-B. Fixed-dose 10 mg daily isotretinoin for acne vulgaris. J Cosmet Dermatol 2017 ↗

Question 03

What are the side effects of isotretinoin (Accutane)?

⚠ Mostly dose-related and reversible

Almost every isotretinoin side effect is dose-related and reverses after the course ends. The common adverse effects are mucocutaneous, musculoskeletal and ophthalmic — dry lips, dry skin, sun sensitivity, joint and muscle aches, and dry eyes — and they generally resolve after the drug is stopped with standard courses.

SystemTypical effectsFrequency
MucocutaneousCheilitis, xerosis, skin fragility, photosensitivityNear-universal
OcularDry eyes, contact lens intoleranceCommon
MusculoskeletalMyalgia, arthralgia, back painCommon
LaboratoryRaised triglycerides, raised transaminasesUncommon / usually mild
ReproductiveTeratogenicityAbsolute contraindication

Recommended monitoring includes liver function tests, a fasting lipid panel, and pregnancy testing for anyone who can become pregnant. Routine full blood count monitoring is not needed in otherwise healthy patients.

📚 Reference: AAD Guidelines of Care for the Management of Acne Vulgaris, JAAD 2024 ↗

📋Get the side-effects checklist by email

Ten body systems in tick-box form — skin, eyes, nose, mouth, mood, joints, gut and the laboratory abnormalities to watch. Print it and fill it in before each appointment.

Sends the checklist link to your inbox. Occasional dermatology updates after. Unsubscribe any time.

Question 04

Does isotretinoin (Accutane) cause purging?

🔴 Up to ~32% in the first month

An early flare is real but not universal. Studies report an initial acne flare in up to about 32% of patients during the first month, mostly mild to moderate in severity.

It is more likely in severe, inflammatory, widespread cystic acne, and can be blunted by starting at a lower dose or adding a short course of prednisone in the first month.

⚠️ Important: A flare is not proof that the drug is working, and it is not therapeutic. Report it — it can and should be treated, since an untreated severe flare risks scarring.

📚 Reference: Acute Acne Flare Following Isotretinoin Administration, Dermatology (Karger) ↗

Question 05

Does isotretinoin (Accutane) cause permanent side effects?

🟢 Long-term data reassuring

Most effects are dose-related and reverse after stopping. In a propensity-matched analysis of 61,894 pairs followed for 6–10 years, isotretinoin was not associated with increased inflammatory bowel disease (HR 0.88) or ulcerative colitis, and lipid elevations were transient.

The genuinely permanent risks are fetal malformation from pregnancy exposure, and scarring from waxing — which must be avoided during treatment and for six months afterwards.

📚 Reference: Gupta N, et al. Isotretinoin Does Not Increase the Risk of IBD: TriNetX Cohort. J Drugs Dermatol 2025 ↗

Question 06

Does isotretinoin (Accutane) cause depression or anxiety?

🟢 No increased population-level risk

Population-level data are reassuring. A meta-analysis of 25 studies including 1,625,891 participants found the 1-year absolute risk of completed suicide, suicide attempt, suicidal ideation and self-harm each below 0.5%, and depression at 3.83%. There was no increased relative risk of psychiatric disorders overall, and isotretinoin users were less likely than non-users to attempt suicide 2 to 4 years after treatment.

⚠️ Still monitor: Guidelines direct clinicians to screen every acne patient — especially those on isotretinoin — for depression, anxiety and suicidal ideation. Population reassurance does not replace individual vigilance, and any new mood change should be reported promptly.

📚 Reference: Tan NKW, et al. Risk of Suicide and Psychiatric Disorders Among Isotretinoin Users. JAMA Dermatol 2024 ↗

Question 07

Does isotretinoin (Accutane) cause hair loss?

🟣 3–6%, dose-related, usually temporary

Uncommon and typically reversible. A systematic review of 22 studies found hair loss in 3.2% of patients on <0.5 mg/kg/day versus 5.7% on ≥0.5 mg/kg/day.

The pattern is telogen effluvium — diffuse, non-scarring shedding. Because the follicles are not damaged, regrowth is expected over roughly 3 to 12 months after stopping. Lowering the daily dose is a reasonable option when shedding is distressing.

📚 Reference: Lytvyn Y, et al. Frequency of isotretinoin-induced hair loss by dose. JAAD International 2022 ↗

Question 08

Can acne come back after isotretinoin (Accutane)?

📊 22.5% relapse · 8.2% second course

In a minority of patients, yes. Among 19,907 patients who completed a course, 22.5% relapsed and 8.2% needed a second isotretinoin course. Higher cumulative dosage was associated with lower rates of both, while female sex predicted higher relapse (HR 1.43). Median time to relapse was 7.5 months.

Key point: Topical retinoid maintenance started after the course is standard practice and is the main modifiable step for holding remission. The cumulative-dose finding is why the calculator above offers a 220 mg/kg target alongside the classic 120–150.

📚 Reference: Lai J, Barbieri JS. Acne Relapse and Isotretinoin Retrial. JAMA Dermatol 2025 ↗

Question 09

What happens if I stop isotretinoin before completing the course?

⚠ No withdrawal — but higher relapse risk

There is no withdrawal syndrome and no taper is needed, but relapse becomes more likely. In a study of 212 patients the overall relapse rate was 37.3%, and was significantly higher in those who still had residual lesions at the end of treatment. The authors advise continuing until complete clinical clearance and then for at least one further month, regardless of cumulative dose.

A larger review of 1,453 patients found that neither daily nor cumulative dose influenced relapse — provided treatment continued for at least 2 months after the acne had fully resolved.

⚠️ Legitimate reasons to stop early include marked transaminase or triglyceride elevation, severe headache, or intolerable side effects. This is a clinical decision, not a failure — the course can be restarted later once the issue resolves.

📚 Reference: Demirci Saadet E. Relapse rate and factors after oral isotretinoin. Dermatol Ther 2021 ↗

Question 10

What happens if I get pregnant while taking isotretinoin (Accutane)?

🔴 Stop immediately — absolute contraindication

Stop isotretinoin at once and contact the prescriber. The FDA label directs that the drug be discontinued immediately and the patient referred to an obstetrician experienced in reproductive toxicity for further evaluation and counselling. Any suspected fetal exposure during treatment or within one month afterwards must be reported.

Major congenital malformations, spontaneous abortion and premature birth have all been documented, and there is no accurate way to determine whether an exposed fetus has been affected.

⚠️ Prevention requirements: Two forms of contraception, used from one month before treatment, throughout, and for one month after the last dose — plus monthly pregnancy testing. No blood donation during treatment or for one month after.

📚 Reference: FDA Prescribing Information — Isotretinoin Capsules (DailyMed) ↗

Question 11

Is laser hair removal safe while on isotretinoin?

💠 Consensus says yes — label says wait

Current expert consensus supports it, despite the older six-month rule. A systematic review of 32 publications covering 1,485 procedures found insufficient evidence to justify delaying manual dermabrasion, superficial chemical peels, cutaneous surgery, laser hair removal, or fractional ablative and non-ablative lasers in patients currently on or recently finished with isotretinoin.

A controlled study of alexandrite, diode and Nd:YAG laser hair removal found no significant difference in side effects versus controls — no blistering, ulceration, keloid or scar formation in either group.

ProcedureConsensus position
Laser hair removal (alexandrite, diode, Nd:YAG)Insufficient evidence to delay
Non-ablative & fractional ablative lasersInsufficient evidence to delay
Superficial chemical peels, minor surgeryInsufficient evidence to delay
Mechanical dermabrasionNot recommended
Fully ablative resurfacingNot recommended
Waxing (hot or cold)Avoid — during + 6 months after
⚠️ Worth knowing: The FDA package insert still advises a six-month delay before cosmetic procedures. Consensus literature has moved on, but practice varies by clinic and country — discuss with your own dermatologist before booking.

📚 Reference: Spring LK, et al. Isotretinoin and Timing of Procedural Interventions. JAMA Dermatol 2017 ↗

Question 12

What skincare products can I use while taking isotretinoin (Accutane)?

🧴 Three steps: cleanse · moisturise · protect

Three products are enough: a gentle non-foaming cleanser, a non-comedogenic moisturiser and an oil-free SPF 30+ sunscreen — everything acidic or exfoliating comes off the shelf until the course ends. Apply a non-comedogenic moisturiser while the skin is still damp after cleansing, avoid abrasive scrubs and exfoliating cleansers, use petroleum jelly or lip balm for dry lips, and use an oil-free broad-spectrum sunscreen of SPF 30 or higher every morning.

CategoryGuidance
Gentle, non-foaming cleanserUse
Non-comedogenic moisturiser (ceramides, squalane)Use
Broad-spectrum SPF 30+ sunscreen, oil-freeUse daily
Petrolatum lip balmUse frequently
Topical retinol / retinoidsAvoid
Benzoyl peroxide or sulfurAvoid
Vitamin C serumsAvoid
AHA / BHA exfoliants (glycolic, salicylic, lactic)Avoid
Vitamin A supplementsAvoid
WaxingAvoid + 6 months after

📚 Reference: American Academy of Dermatology — Isotretinoin: Side Effects and Skin Care ↗

Question 13

When should isotretinoin be stopped? What is the current recommended endpoint?

🎯 Clear, then one more month — dose is a guide, not a finish line

The endpoint is clinical, not arithmetic. Continue isotretinoin until the patient is clear of active inflammatory acne, and then keep going for at least one further month — often one to two months — before stopping. The familiar 120–150 mg/kg cumulative range is used as a planning guide, not as an absolute requirement that must be reached before treatment can end.

Situation at the planned end dateWhat the guideline supports
Clear, and has stayed clear for 1–2 monthsStop
Clear only in the last few weeksContinue 1–2 more months
Residual active inflammatory lesionsDo not stop yet
120–150 mg/kg reached but acne still activeCumulative target alone is not a reason to stop
Clear and stable, but below 120 mg/kgStopping is reasonable
Key point: The 2025 EuroGuiDerm update states that an evidence-based cumulative dose target for preventing relapse cannot currently be defined. Use the calculator above to plan the course, then let the skin decide the finish date.

📚 Reference: EuroGuiDerm Guideline for the Treatment of Acne — Update 2025 (JEADV, short version) ↗ · Summary of the isotretinoin dosing recommendations ↗

🩺For clinicians: EuroGuiDerm 2025 isotretinoin dosing summary

A one-page summary of the 2025 update — dosing recommendations, the cumulative-dose position, corticosteroid combination and the stopping endpoint, with the source references.

Sends the summary link to your inbox. Occasional guideline updates after. Unsubscribe any time.

References

  1. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024.
  2. Cohort analysis of acne relapse and isotretinoin retrial. JAMA Dermatology. 2025;161(4):367–374. doi:10.1001/jamadermatol.2024.5416
  3. Tan J, Knezevic S, Boyal S, et al. Evaluation of evidence for acne remission with oral isotretinoin cumulative dosing of 120–150 mg/kg. J Cutan Med Surg. 2016;20:13–20.
  4. Blasiak RC, et al. High-dose isotretinoin treatment and the rate of retrial, relapse and adverse effects. JAMA Dermatol. 2013.

Medical disclaimer: This calculator is an educational reference for clinicians and patients already under dermatological care. It does not constitute medical advice, does not account for comorbidities, drug interactions, hepatic or lipid abnormalities, or pregnancy status, and must not be used to start, stop or alter isotretinoin therapy without a licensed prescriber.

This website uses cookies.

This website uses cookies.

Exit mobile version